RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma-Reference-Cited by-同舟云学术

RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

Published:2020-05-18 Issue:6 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Smith Henry G¹,Jamal Kunzah²,Dayal Jasbani HS³,Tenev Tencho²,Kyula‐Currie Joan¹,Guppy Naomi²,Gazinska Patrycja²,Roulstone Victoria¹,Liccardi Gianmaria²,Davies Emma¹,Roxanis Ioannis²³⁴⁵,Melcher Alan A⁶,Hayes Andrew J⁷,Inman Gareth J³⁸,Harrington Kevin J¹,Meier Pascal²^ORCID

Affiliation:

1. Targeted Therapy Team The Institute of Cancer Research London UK

2. The Breast Cancer Now Toby Robins Research Centre The Institute of Cancer Research London UK

3. Cancer Research UK Beatson Institute Glasgow UK

4. Division of Molecular Pathology The Institute of Cancer Research London UK

5. Royal Free London NHS Foundation Trust London UK

6. The Translational Immunology Team The Institute of Cancer Research London UK

7. The Sarcoma and Melanoma Unit The Royal Marsden Hospital London UK

8. Institute of Cancer Sciences University of Glasgow Glasgow UK

Funder

Breast Cancer Now

Cancer Research UK